These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17261412)

  • 21. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.
    Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
    Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
    Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
    Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
    J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
    Young JJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stents, restenosis and revascularization.
    Ramcharitar S; Gaster AL; Daemen J; Serruys P
    Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering aspects of stents design and their translation into clinical practice.
    Sangiorgi G; Melzi G; Agostoni P; Cola C; Clementi F; Romitelli P; Virmani R; Colombo A
    Ann Ist Super Sanita; 2007; 43(1):89-100. PubMed ID: 17536159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xience V everolimus-eluting coronary stent.
    Kukreja N; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioabsorbable drug-eluting stents: the future of coronary angioplasty?
    Macaya C; Moreno R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):598-9. PubMed ID: 18679382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic science review: nitric oxide--releasing prosthetic materials.
    Varu VN; Tsihlis ND; Kibbe MR
    Vasc Endovascular Surg; 2009; 43(2):121-31. PubMed ID: 18799500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late stent thrombosis: problem or not?
    Somberg J; Weinberger J
    Am J Cardiol; 2007 Apr; 99(7):1020-3. PubMed ID: 17398205
    [No Abstract]   [Full Text] [Related]  

  • 37. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stent implantation: technique matters, more than ever.
    De Bruyne B; Barbato E
    JACC Cardiovasc Interv; 2008 Feb; 1(1):32-3. PubMed ID: 19393141
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
    Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
    Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.